Molecular-Biology-Driven Treatment for Metastatic Colorectal Cancer

Molecular-Biology-Driven Treatment for Metastatic Colorectal Cancer

Background: Metastatic CRC (mCRC) is a molecular heterogeneous disease. The aim of this review is to give an overview of molecular-driven treatment of mCRC patients. Methods: A review of clinical trials, retrospective studies and case reports was performed regarding molecular biomarkers with therape...

Full description

Bibliographic Details
Main Authors: Eleonora Lai, Nicole Liscia, Clelia Donisi, Stefano Mariani, Simona Tolu, Andrea Pretta, Mara Persano, Giovanna Pinna, Francesca Balconi, Annagrazia Pireddu, Valentino Impera, Marco Dubois, Marco Migliari, Dario Spanu, Giorgio Saba, Silvia Camera, Francesca Musio, Pina Ziranu, Marco Puzzoni, Laura Demurtas, Valeria Pusceddu, Manuela Dettori, Elena Massa, Francesco Atzori, Mariele Dessì, Giorgio Astara, Clelia Madeddu, Mario Scartozzi
Format: Article
Language:English
Published: MDPI AG 2020-05-01
Series:Cancers
Subjects:
metastatic colorectal cancer
molecular biomarkers
therapeutic implications
tailored treatment
Online Access:https://www.mdpi.com/2072-6694/12/5/1214

Internet

https://www.mdpi.com/2072-6694/12/5/1214

Similar Items